FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40723111000001108: Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jul 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2306421000001115 Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2306441000001113 Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Is a Generic Palforzia 0.5mg oral powder in capsules for opening 2 capsule true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has AMP Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has specific active ingredient Peanut protein (as defatted powder of Arachis hypogaea L., semen [peanuts]) true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has dispensed dose form Powder true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Palforzia 0.5mg oral powder in capsules for opening (Aimmune Therapeutics UK Ltd) 2 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start